Foster Dykema Cabot & Co’s CVS Health CVS Stock Holding History

Foster Dykema Cabot & Co’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$48K	Hold	694	–	–	0.01%	161
2023 Q2	$48K	Hold	694	–	–	0.01%	166
2023 Q1	$52K	Buy	+694	New	+$58.2K	0.01%	142
2016 Q4	–	Sell	-46,887	Closed	-$4.17M	–	110
2016 Q3	$4.17M	Sell	46,887 -430	-0.9%	-$40.6K	0.91%	27
2016 Q2	$4.53M	Sell	47,317 -4,608	-9%	-$459K	1.06%	21
2016 Q1	$5.39M	Sell	51,925 -715	-1%	-$69.5K	1.31%	19
2015 Q4	$5.15M	Sell	52,640 -850	-2%	-$83.2K	1.29%	20
2015 Q3	$5.16M	Sell	53,490 -820	-2%	-$86.2K	1.32%	21
2015 Q2	$5.7M	Sell	54,310 -13,175	-20%	-$1.35M	1.48%	21
2015 Q1	$6.96M	Buy	67,485 +1,355	+2%	+$137K	1.7%	21
2014 Q4	$6.37M	Sell	66,130 -2,028	-3%	-$179K	1.51%	25
2014 Q3	$5.42M	Buy	68,158 +182	+0.3%	+$14.3K	1.32%	25
2014 Q2	$5.12M	Buy	67,976 +4,095	+6%	+$309K	1.22%	24
2014 Q1	$4.78M	Buy	63,881 +2,535	+4%	+$179K	1.19%	26
2013 Q4	$4.39M	Buy	+61,346	New	+$3.94M	1.17%	26

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Foster Dykema Cabot & Co's CVS Position: Q3 2023 in Review

Foster Dykema Cabot & Co held its CVS Health (CVS) position steady in Q3 2023 at 694 shares worth $48K. The position accounts for 0.01% of the portfolio, ranked #161.

Foster Dykema Cabot & Co first reported a position in CVS in Q4 2013 and has held it in 15 quarters since. The position peaked at $6.96M in Q1 2015. 2,113 funds tracked by Wall St. Rank hold CVS as of Q3 2023.

Foster Dykema Cabot & Co held 694 shares of CVS Health worth $48K as of Q3 2023.
Foster Dykema Cabot & Co left its CVS Health share count unchanged in Q3 2023.
CVS Health made up 0.01% of Foster Dykema Cabot & Co's portfolio in Q3 2023, its #161 holding.
Foster Dykema Cabot & Co first reported a position in CVS Health in Q4 2013 and has held it in 15 quarters since.
Foster Dykema Cabot & Co's CVS Health position peaked at $6.96M in Q1 2015.
2,113 funds tracked by Wall St. Rank held CVS Health as of Q3 2023.

Based on Foster Dykema Cabot & Co's 13F filing for Q3 2023, filed 14 Nov 2023.